We found that multiple cancer types exhibited a significant association between patient prognosis and TGFβ2 expression including breast, lung, blood, ovarian, prostate, brain and colon cancer (Figure 2A–H). The gene discussed is TGFB2; the disease is malignant colon neoplasm.